Cellectis
CLLS
79 hedge funds and large institutions have $247M invested in Cellectis in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 12 closing their positions.
108% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 12
85% more capital invested
Capital invested by funds: $133M → $247M (+$114M)
20% more funds holding
Funds holding: 66 → 79 (+13)
8% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 24
1.26% less ownership
Funds ownership: 34.03% → 32.77% (-1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$18.7M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$4.21M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$3.65M |
| 4 |
6CM
683 Capital Management
New York
|
+$3.04M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$2.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.4M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
-$8.57M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$8.44M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.25M |
CLLS Hedge Fund Activity: Q2 2020 in Review
79 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2020, worth a combined $247M — up 85% from $133M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new CLLS positions and 12 closed out — a net gain of 13 holders — while 22 added to existing stakes and 24 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $18.7M. The largest seller was Fidelity Investments, cutting an estimated $20.4M.
- 79 institutional investors held Cellectis (CLLS) as of Q2 2020, up from 66 in Q1 2020.
- Funds reported $247M of Cellectis stock for Q2 2020, up 85% quarter-over-quarter.
- 25 funds opened new Cellectis positions in Q2 2020 and 12 closed out, a net change of +13 holders.
- The largest Cellectis buyer in Q2 2020 was ARK Investment Management, an estimated $18.7M added.
- The largest Cellectis seller in Q2 2020 was Fidelity Investments, an estimated $20.4M sold.
Based on aggregated 13F filings for Q2 2020.